These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18007080)

  • 21. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High mobility group I-C protein in astrocytoma and glioblastoma.
    Akai T; Ueda Y; Sasagawa Y; Hamada T; Date T; Katsuda S; Iizuka H; Okada Y; Chada K
    Pathol Res Pract; 2004; 200(9):619-24. PubMed ID: 15497774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
    Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
    Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas.
    Kotoula V; Barbanis S; Nikolakaki E; Koufoyannis D; Papadimitriou CS; Karkavelas G
    Acta Neuropathol; 2004 May; 107(5):443-51. PubMed ID: 14986029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nestin expression in astrocytic tumors delineates tumor infiltration.
    Kitai R; Horita R; Sato K; Yoshida K; Arishima H; Higashino Y; Hashimoto N; Takeuchi H; Kubota T; Kikuta K
    Brain Tumor Pathol; 2010 Apr; 27(1):17-21. PubMed ID: 20425043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
    Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
    Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
    Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
    Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
    Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the DNA repair enzyme, N-methylpurine-DNA glycosylase (MPG) in astrocytic tumors.
    Kim NK; Ahn JY; Song J; Kim JK; Han JH; An HJ; Chung HM; Joo JY; Choi JU; Lee KS; Roy R; Oh D
    Anticancer Res; 2003; 23(2B):1417-23. PubMed ID: 12820404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DLC2/StarD13 plays a role of a tumor suppressor in astrocytoma.
    El-Sitt S; Khalil BD; Hanna S; El-Sabban M; Fakhreddine N; El-Sibai M
    Oncol Rep; 2012 Aug; 28(2):511-8. PubMed ID: 22614672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of Cx43 in astrocytic tumors.
    Pu P; Xia Z; Yu S; Huang Q
    Clin Neurol Neurosurg; 2004 Dec; 107(1):49-54. PubMed ID: 15567553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The expression of plasminogen activator inhibitor-1 (PAI-1) gene in human astrocytomas].
    Bu X; Zhang X; Cao W
    Zhonghua Bing Li Xue Za Zhi; 1998 Dec; 27(6):433-5. PubMed ID: 11244954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Fas/APO-1 during the progression of astrocytomas.
    Tachibana O; Nakazawa H; Lampe J; Watanabe K; Kleihues P; Ohgaki H
    Cancer Res; 1995 Dec; 55(23):5528-30. PubMed ID: 7585627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
    Hara A; Okayasu I
    Acta Neuropathol; 2004 Jul; 108(1):43-8. PubMed ID: 15088099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression in childhood primary brain tumors of NY-ESO-1, a cancer/testis antigen: an immunohistochemical study.
    Bodey B; Bodey V; Siegel SE
    In Vivo; 2008; 22(1):83-7. PubMed ID: 18396787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mdr1 mRNA expression differs between grade III astrocytomas and glioblastomas.
    Kirches E; Oda Y; Von Bossanyi P; Diete S; Schneider T; Warich-Kirches M; Dietzmann K
    Clin Neuropathol; 1997; 16(1):34-6. PubMed ID: 9020393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas.
    Reifenberger G; Kaulich K; Wiestler OD; Blümcke I
    Acta Neuropathol; 2003 Apr; 105(4):358-64. PubMed ID: 12624789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and release of CD14 in astrocytic brain tumors.
    Deininger MH; Meyermann R; Schluesener HJ
    Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
    Erdamar S; Bagci P; Oz B; Dirican A
    J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.